首页> 外文期刊>The Journal of biological chemistry >Structural Basis of Rev1-mediated Assembly of a Quaternary Vertebrate Translesion Polymerase Complex Consisting of Rev1, Heterodimeric Polymerase (Pol) ζ, and Pol κ
【24h】

Structural Basis of Rev1-mediated Assembly of a Quaternary Vertebrate Translesion Polymerase Complex Consisting of Rev1, Heterodimeric Polymerase (Pol) ζ, and Pol κ

机译:Rev1介导的季脊椎动物转化聚合酶复合物组成的结构基础,由Rev1,异二聚体聚合酶(Pol)α和Polκ

获取原文
           

摘要

DNA synthesis across lesions during genomic replication requires concerted actions of specialized DNA polymerases in a potentially mutagenic process known as translesion synthesis. Current models suggest that translesion synthesis in mammalian cells is achieved in two sequential steps, with a Y-family DNA polymerase (κ, η, ι, or Rev1) inserting a nucleotide opposite the lesion and with the heterodimeric B-family polymerase ζ, consisting of the catalytic Rev3 subunit and the accessory Rev7 subunit, replacing the insertion polymerase to carry out primer extension past the lesion. Effective translesion synthesis in vertebrates requires the scaffolding function of the C-terminal domain (CTD) of Rev1 that interacts with the Rev1-interacting region of polymerases κ, η, and ι and with the Rev7 subunit of polymerase ζ. We report the purification and structure determination of a quaternary translesion polymerase complex consisting of the Rev1 CTD, the heterodimeric Pol ζ complex, and the Pol κ Rev1-interacting region. Yeast two-hybrid assays were employed to identify important interface residues of the translesion polymerase complex. The structural elucidation of such a quaternary translesion polymerase complex encompassing both insertion and extension polymerases bridged by the Rev1 CTD provides the first molecular explanation of the essential scaffolding function of Rev1 and highlights the Rev1 CTD as a promising target for developing novel cancer therapeutics to suppress translesion synthesis. Our studies support the notion that vertebrate insertion and extension polymerases could structurally cooperate within a megatranslesion polymerase complex (translesionsome) nucleated by Rev1 to achieve efficient lesion bypass without incurring an additional switching mechanism.
机译:在基因组复制期间的病变中的DNA合成需要在称为Transion合成的潜在致突变过程中的专用DNA聚合酶的齐节作用。目前的模型表明,哺乳动物细胞中的翻塑合成以两种顺序步骤实现,其中Y家族DNA聚合酶(κ,η,ι或Rev1)插入损伤与异二聚体B系聚合酶的核苷酸,组成催化Rev3亚基和附件Rev7亚基,取代插入聚合酶以进行底漆延伸超过病变。脊椎动物中有效的翻塑合成需要Rev1的C末端结构域(CTD)的支架功能,其与聚合酶κ,η和1的Rev1相互作用区域相互作用,并用聚合酶α的Rev7亚基相互作用。我们报告了由Rev1 CTD,异二聚体POLα复合物和POLκNEV1相互作用区域组成的季静脉翻转聚合酶复合物的纯化和结构测定。使用酵母双杂化测定来鉴定翻塑聚合酶复合物的重要界面残留物。这种季铵转过含量聚合酶络合物的结构阐明包括Rev1 CTD桥接的插入和延伸聚合酶提供了Rev1的基本脚手架功能的第一个分子解释,并突出了Rev1 CTD作为开发新型癌症治疗剂以抑制转锁的有希望的靶标合成。我们的研究支持脊椎动物插入和延伸聚合酶的观念可以在通过Rev1核化的Megatlansion聚合酶复合物(Translaionsome)内在结构上配合,以实现有效的病变旁路而不产生额外的切换机构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号